Mark Sulkowski
Impact in
- Hepatology top 0.01%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 0.02%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 334
- Hepatitis C virus research 332
- Liver Disease and Transplantation 14
- Epidemiology 173
- Liver Disease Diagnosis and Treatment 111
- Hepatitis B Virus Studies 110
- Co-authors
- David L. Thomas (58 shared papers)John G. McHutchison (46 shared papers)Andrew J. Muir (16 shared papers)Richard K. Sterling (29 shared papers)Ira M. Jacobson (36 shared papers)Mark Nelson (4 shared papers)Francesca J. Torriani (5 shared papers)Ricard Solà (2 shared papers)
- Journals
- Journal of Hepatology (69 papers)Hepatology (36 papers)Gastroenterology (32 papers)Clinical Infectious Diseases (23 papers)Journal of Viral Hepatitis (22 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Mark Sulkowski
401 papers receiving 26.9k citations
Mark Sulkowski's Hit Papers
Peers
Comparison fields: 5 of 153
- Hepatology 19.9k
- Epidemiology 14.0k
- Infectious Diseases 4.2k
- Virology 985
- Transplantation 373
Countries citing papers authored by Mark Sulkowski
This map shows the geographic impact of Mark Sulkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sulkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sulkowski more than expected).
Fields of papers citing papers by Mark Sulkowski
This network shows the impact of papers produced by Mark Sulkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sulkowski. The network helps show where Mark Sulkowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Sulkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 418 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡ Hit paper breakdown → | 2006 | 3584 |
| 2 | Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Hit paper breakdown → | 2009 | 2731 |
| 3 | Boceprevir for Untreated Chronic HCV Genotype 1 Infection Hit paper breakdown → | 2011 | 1945 |
| 4 | Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection Hit paper breakdown → | 2009 | 915 |
| 5 | Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection Hit paper breakdown → | 2009 | 831 |
| 6 | Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection Hit paper breakdown → | 2000 | 778 |
| 7 | Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection Hit paper breakdown → | 2011 | 579 |
| 8 | Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection Hit paper breakdown → | 2017 | 523 |
| 9 | 2002 | 428 | |
| 10 | Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin Hit paper breakdown → | 2014 | 410 |
| 11 | 2002 | 365 | |
| 12 | 2002 | 358 | |
| 13 | 2010 | 351 | |
| 14 | 2003 | 321 | |
| 15 | 2015 | 266 | |
| 16 | 2007 | 266 | |
| 17 | 2007 | 250 | |
| 18 | 2004 | 240 | |
| 19 | 2007 | 236 | |
| 20 | 2015 | 230 |
About Mark Sulkowski
Mark Sulkowski is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Genetics, having authored 418 papers that have together received 27.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (332 papers), Liver Disease Diagnosis and Treatment (111 papers), Hepatitis B Virus Studies (110 papers), HIV/AIDS drug development and treatment (59 papers), Systemic Lupus Erythematosus Research (32 papers), Chronic Lymphocytic Leukemia Research (21 papers), HIV-related health complications and treatments (18 papers) and Liver Disease and Transplantation (14 papers). The work is most often cited by research in Hepatology (19.9k citations), Epidemiology (14.0k citations), Infectious Diseases (4.2k citations), Virology (985 citations) and Transplantation (373 citations). Mark Sulkowski has collaborated with scholars based in United States, Germany and France. Frequent co-authors include David L. Thomas, John G. McHutchison, Andrew J. Muir, Richard K. Sterling, Ira M. Jacobson, Mark Nelson, Francesca J. Torriani, Ricard Solà, Nathan Clumeck and Doug Dieterich. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, Clinical Infectious Diseases and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.